Tritiated haloperidol and tritiated dopamine label postsynaptic dopamine
receptors in mammalian brain. Clinical potencies of butyrophenones,
phenothiazines, and related drugs correlate closely with their ability to
inhibit tritiated haloperidol binding. These binding methods provide a
simple in vitro means for evaluating new drugs as potential
antischizophrenic agents.Abstract Teaser